HF

Stallion Uranium Drilling Intersects Anomalous Radioactivity

Retrieved on: 
Tuesday, April 2, 2024

The survey data when compiled and modeled with all available historical data showed the key characteristics for potential uranium mineralization.

Key Points: 
  • The survey data when compiled and modeled with all available historical data showed the key characteristics for potential uranium mineralization.
  • To best refine drill targets Stallion utilized the latest technology to complete an advanced ground TDEM survey over the target area.
  • Stallion Uranium requests multi-element analysis by ICP-MS and ICP-OES using total (HF:NHO3:HClO4) and partial digestion (HNO3:HCl), boron by fusion.
  • The foregoing scientific and technical disclosures for Stallion Uranium have been reviewed by Darren Slugoski, P.Geo., VP Exploration, a registered member of the Professional Engineers and Geoscientists of Saskatchewan.

Kingspan Insulated Panels North America Announces New Facility Coming to Mattoon, Illinois

Retrieved on: 
Wednesday, March 27, 2024

DELAND, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Kingspan Insulated Panels North America today announces it will be opening a new facility in Mattoon, Illinois.

Key Points: 
  • DELAND, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Kingspan Insulated Panels North America today announces it will be opening a new facility in Mattoon, Illinois.
  • With the new Mattoon site, Kingspan will have two strategic locations to take advantage of business growth across North America.
  • “As a result of continued growth and optimism for the future, the addition of this new facility complements our existing footprint in North America, giving us better access to our customer base,” said Alswinn Kieboom, president of Kingspan Insulated Panels North America.
  • For more information on Kingspan Insulated Panels North America, visit www.kingspanpanels.us.

Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo

Retrieved on: 
Monday, March 25, 2024

In a post-hoc analysis of data from the 10,584 patients in the SCORED Phase 3 clinical trial, 213 all-cause stroke events occurred, including 29 (13.6%) fatal events.

Key Points: 
  • In a post-hoc analysis of data from the 10,584 patients in the SCORED Phase 3 clinical trial, 213 all-cause stroke events occurred, including 29 (13.6%) fatal events.
  • Sotagliflozin reduced the risk of all-cause stroke by 34%, with 1.2 events per 100 patient-years in the sotagliflozin group and 1.8 events per 100 patient-years in the placebo group.
  • Similarly, sotagliflozin reduced the risk of ischemic stroke by 32%, with 0.8 events per 100 patient-years in the sotagliflozin group and 1.2 events per 100 patient-years in the placebo group.
  • Candidate, University of Michigan, Ann Arbor, Michigan
    Study researchers found that sotagliflozin inhibits platelet activation through simultaneously targeting SGLT1 and SGLT2.

Globex Acquires Gold Exploration Target in Arizona, USA

Retrieved on: 
Thursday, March 21, 2024

The project area is at the northernmost margin of the historic Gold Basin Mining District.

Key Points: 
  • The project area is at the northernmost margin of the historic Gold Basin Mining District.
  • In the area covered by Globex’s Salt Spring property Globex has identified 14 small mine workings and at least 15 prospects.
  • Globex already carried out preliminary fieldwork including geological mapping and collected a total of 70 rock samples.
  • Obtained gold values above 10 g/t were re-analyzed via fire assay of a 30 g subsample and gravimetric determination.

HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Retrieved on: 
Tuesday, March 12, 2024

Recent guidelines propose N-terminal pro-B-type natriuretic peptide (blood test for NT-proBNP protein marker) for recognition of asymptomatic left ventricular (LV) dysfunction (Stage B Heart Failure, SBHF) in type 2 diabetes (T2DM) patients.

Key Points: 
  • Recent guidelines propose N-terminal pro-B-type natriuretic peptide (blood test for NT-proBNP protein marker) for recognition of asymptomatic left ventricular (LV) dysfunction (Stage B Heart Failure, SBHF) in type 2 diabetes (T2DM) patients.
  • Accordingly, the study sought to evaluate whether an AI-ECG model based on MyoVista® wavECG™ features was superior to NT-proBNP, as well as a conventional screening tool—the Atherosclerosis Risk in Communities (ARIC) HF risk score, in SBHF screening among patients with T2DM.
  • This independent study provides evidence of the clinical and diagnostic capabilities of AI-ECG, and specifically our MyoVista wavECG technology, to potentially advance current standards of care for heart screening in diabetic patients.” said Andrew Simpson, Chief Executive Officer of HeartSciences.
  • “Globally cardiovascular disease accounts for approximately one-third of all annual deaths and AI-ECG is set to change medicine by providing the opportunity to detect heart disease earlier and more effectively, not only for diabetic patients, but also for a significant number of at-risk patients.

Bill Introduced in Minnesota Would Increase Access To Genetic Testing

Retrieved on: 
Thursday, March 28, 2024

ST. PAUL, Minn., March 28, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, applauds Representative Patty Acomb (D-Minnetonka) for introducing legislation that would eliminate financial barriers to clinically appropriate genetic testing, as well as the recommended screenings based on the results of that testing.

Key Points: 
  • In Minnesota, more than 5,480 people will be diagnosed with breast cancer and 630 are expected to die of the disease in 2024 alone.
  • In the U.S., 5-10% of breast cancers are related to a known inherited gene mutation.
  • HF 5050 , introduced by Rep Acomb, eliminates the patient out-of-pocket costs for multi-gene panel testing for inherited gene mutations and evidence-based screenings, ensuring individuals have access to critical information regarding their lifetime cancer risk and recommended early detection and cancer surveillance.
  • Germline testing is a type of test that looks for inherited mutations that have been present in every cell of the body since birth.

Auden Unveils a Comprehensive Satellite Communication Solution at the Satellite 2024

Retrieved on: 
Tuesday, March 19, 2024

Auden has significantly advanced its decades of expertise in array antenna communication system design, introducing groundbreaking enhancements in shared antenna configurations.

Key Points: 
  • Auden has significantly advanced its decades of expertise in array antenna communication system design, introducing groundbreaking enhancements in shared antenna configurations.
  • Auden is also proactively adopting the 3GPP R18 standards, incorporating NTN communication protocols, and facilitating the integration of next-generation base-band modules with satellite operators.
  • Daniel Chang, Chairman of Auden, said, "We are delighted to collaborate with Compal, leveraging the strengths of both parties to introduce a comprehensive satellite communication solution.
  • We invite you to visit us at the exhibition to learn more about this groundbreaking satellite communication solution.

ATI names Vaishali Bhatia General Counsel and Chief Compliance Officer

Retrieved on: 
Thursday, March 14, 2024

DALLAS, March 14, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) has named Vaishali Bhatia Senior Vice President, General Counsel and Chief Compliance Officer, effective March 20, 2024.

Key Points: 
  • DALLAS, March 14, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) has named Vaishali Bhatia Senior Vice President, General Counsel and Chief Compliance Officer, effective March 20, 2024.
  • Bhatia reports to ATI Board Chair and CEO Robert S. Wetherbee and serves on the company's Executive Council.
  • Bhatia succeeds ATI Chief Legal and Compliance Officer Elliot Davis, who announced his intention to retire effective October 1, 2024.
  • Bhatia joins ATI from HF Sinclair Corporation (HF Sinclair), where she's served as Executive Vice President since 2023, and General Counsel and Corporate Secretary since 2019.

High Prevalence of Cognitive Impairment in Patients with Heart Failure Shown to Negatively Impact Disease Self-Management

Retrieved on: 
Tuesday, March 12, 2024

The Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement published today in the Journal of Cardiac Failure (JCF), indicates that clinicians have a responsibility to recognize and address cognitive impairment as an integral component of personalized care for patients with heart failure (HF).

Key Points: 
  • The Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement published today in the Journal of Cardiac Failure (JCF), indicates that clinicians have a responsibility to recognize and address cognitive impairment as an integral component of personalized care for patients with heart failure (HF).
  • Heart failure clinicians should be equipped with tools to assess and identify markers for cognitive impairment.
  • Cognitive Impairment in Heart Failure outlines several domains affected by cognitive impairment including learning and memory, executive function, complex attention, perceptual-motor function, language, and social cognition.
  • The Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement is available online in the JCF at www.onlinejcf.com .

Lion One Provides Update on Tuvatu Operations in Fiji

Retrieved on: 
Monday, March 4, 2024

North Vancouver, British Columbia--(Newsfile Corp. - March 4, 2024) - Lion One Metals Limited (TSXV: LIO) (OTCQX: LOMLF) (ASX: LLO) ("Lion One" or the "Company") is pleased to provide an update on ongoing operations at the company's 100% owned Tuvatu Alkaline Gold Project in Fiji.

Key Points: 
  • North Vancouver, British Columbia--(Newsfile Corp. - March 4, 2024) - Lion One Metals Limited (TSXV: LIO) (OTCQX: LOMLF) (ASX: LLO) ("Lion One" or the "Company") is pleased to provide an update on ongoing operations at the company's 100% owned Tuvatu Alkaline Gold Project in Fiji.
  • The Tuvatu project is currently in the pilot plant stage of operations.
  • The focus of mining operations to date has been on the development of underground access.
  • Diamond drill core samples are logged and split by Lion One personnel on site and delivered to the Lion One Laboratory for preparation and analysis.